bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung

Modern Pathology

Volumn 9, Issue 5, 1996, Pages 484-490

  Coppola, Domenico ^a   Clarke, Martha ^a   Landreneau, Rodney ^a   Weyant, Robert J ^a   Cooper, David ^a   Yousem, Samuel A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atypical carcinoid; bcl 2; Carcinoid; CD44; Immunohistochemistry; Neuroendocrine carcinoma; p53; Small cell carcinoma

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOID TUMOR; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROTO-ONCOGENE PROTEINS C-BCL-2; STEREOISOMERISM; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029941373     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Minna JD, Pass H, Galstein E, Ihde D: Cancer of the lung. In Cancer, Principle and Practice of Oncology, edited by DeVita VT, Hellman S, Rosenberg SA, p 591. Philadelphia, Lippincott, 1989
2. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y: Expression of bcl in small cell lung carcinoma cells. Cancer Res 54:6, 1994
3. Ben-Ezra JM, Kornstein MJ, Grimes MM, Krystal G: Small cell carcinomas of the lung express the bcl protein. Am J Pathol 145:1036, 1994
4. Lohmann DR, Fesseler B, Putz B, et al.: Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. Cancer Res 53:5797, 1993
5. Lohmann D, Putz B, Reich U, et al.: Mutational spectrum of the p53 gene in human small cell lung cancer and relationship to clinicopathologic data. Am J Pathol 142:907, 1993
6. Takahashi T, Nau MM, Chiba I, et al.: p53: A frequent target for genetic abnormalities in lung cancer. Science 246:491, 1989
7. D'Amico D, Carbone D, Mitsodomi T, et al.: High frequency of somatically acquired p53 mutations in small cell lung cancer cell lines and tumors. Oncogene 7:339, 1992
8. Penno MB, August JT, Baylin SB, et al.: Expression of CD44 in human lung tumors. Cancer Res 54:1381, 1994
9. Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA: Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer 8(Suppl):110, 1994
10. Washimi O, Ueda R, Ariyoshi Y, et al.: Expression of CD44 variant isoforms in normal and neoplastic cells of lung. Jpn J Cancer Res 85:1112, 1994
11. Arrigoni MG, Woolner LB, Bernatz PE: Atypical carcinoid tumors of lung. J Thorac Cardiovasc Surg Pathol 64:413, 1972
12. VanderBerg FM, Baas IO, Polak MM, Offerhaus JA: Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol 142:381, 1993
13. Shi SR, Key ME, Kalza KL: Antigen retrieval in formalin-fixed paraffin-embedded tissues. An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741, 1991
14. Sameshima Y, Matsuno Y, Hirohashi S, et al.: Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small cell lung carcinoma. Oncogene 7:451, 1992
15. Banks L, Matlashewski G, Crowford L: Isolation of human p53 specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159:529, 1986
16. Soussi T, Caron de Fromentel C, May P: Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945, 1990
17. Monaghan P, Robertson D, Amos TAS, et al.: Ultrastructural localization of bcl protein. J Histochem Cytochem 40:1819, 1992
18. Evan GI, Wyllie AH, Gilbert CS, et al.: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119, 1992
19. Shiy, Glynn JM, Guilbert LJ, et al: Role for c-myc in activation-induced apoptotic cell death in T-cell hybridomas. Science 257:212, 1992
20. Bissonnette R, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl. Nature 359:552, 1992
21. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl protooncogene. Nature 359:554, 1992
22. Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML: Expression in non-Hodgkin's lymphoma of the bcl protein associated with the (1418) translocation. N Engl J Med 318: 1638, 1988
23. Bronner M, Culin C, Reed J, Furth E: bcl protooncogene and the gastrointestinal mucosal epithelial tumor progression model as related to proposed morphologic and molecular oncogenetic sequences (abstract). Lab Invest 68: 43A, 1993
24. McDonnell TJ, Troncoso P, Brisbay SM, et al: Expression of the protooncogene bcl in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940, 1992
25. Lu QL, Elia G, Lucas S, Thomas JA: bcl protooncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 53:29, 1993
26. Bhargava V, Kell DL, Van de Rijn M, Warnke RA: bcl immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535, 1994
27. Pezzella F, Turley H, Kuzu I, et al.: bcl protein in non-small cell lung carcinoma. N Engl J Med 329:690, 1993
28. Ohmori T, Podack ER, Nishio K, et al.: Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC CPT ADM) is inhibited by bcl. Biochem Biophys Res Commun 192:30, 1993
29. Tsujimoto Y: Stress-resistence conferred by high levels of bd-a protein in human B lymphoblastoid cells. Oncogene 4:1331, 1993
30. Lotem J, Sachs L: Regulation by bel, c-myc, and p53 of susceptibility to induction of apoptosis by heat-shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cell. Cell Growth Differ 4:41, 1993
31. Haldar S, Negrini M, Monne M, Sabbioni S, Croce C: Down-regulation of bcl by p53 in breast cancer cells. Cancer Res 54:2095, 1994
32. Stamenkovic I, Amiot M, Pesando JM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057, 1989
33. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principle cell surface receptor for hyaluronate. Cell 61:1303, 1990
34. Wayner EA, Carter WG: Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique α and common β substrate. J Cell Biol 105:1873, 1987
35. Gunthert U, Hofmann M, Rudy W, et al.: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
36. Hofmann M, Rudy W, Zoller M, et al.: CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292, 1991
37. Tanabe KK, Ellis LM, Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725, 1993
38. Finn L, Dougherty G, Finley G, et al.: Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem Biophysic Res Commun 200:1015, 1994
39. Joensun H, Klemi PJ, Toikkanen S, Jalkanen S: Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 143:867, 1993
40. Washington MK, Gottfried MR, Telen MJ: Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Lab Invest 68:52A, 1993
41. Falco JP, Baylin SB, Lupu R, et al.: V-rasH induces non-small cell phenotype with associated growth factors and receptors, in a small cell lung cancer cell line. Lab Clin Invest 85:1740, 1990
42. Mabry M, Nalkin BD, Falco JP, Barr LF, Baylin SB: Transition between lung cancer phenotypes: Implications for tumor progression. Cancer Cells 3:53, 1991
43. Mabry M, Nakagawa T, Nelkin BD, et al.: V-Ha-ras oncogene insertion: A model for tumor progression in human small cell lung cancer. Proc Natl Acad Sci U S A 85:6523, 1988
44. Sy MS, Guo YJ, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859, 1991